Insights

Expanding Product Portfolio Innovus Pharmaceuticals has a strong track record of launching over-the-counter products in various health segments, including nasal sprays, pain relief, and urinary health. This presents opportunities to cross-sell or bundle complementary wellness products to healthcare providers and retail channels.

Geographic Growth Opportunities With recent product launches in Canada and a focus on in-home treatments, there is potential to expand into additional international markets where demand for OTC and consumer health products is rising, especially in regions emphasizing self-care and remote healthcare.

Technological Engagement Utilizing a digital tech stack including live chat, social media, and online analytics, Innovus effectively engages consumers online. This offers scope to develop targeted digital marketing campaigns to increase brand awareness and drive online sales.

Market Niche Focus Specialization in clinically proven consumer health products for sensitive health issues like sexual health, respiratory, and pain management suggests sales potential through healthcare practitioners and pharmacies that focus on these niche segments.

Financial Viability With revenues between one to ten million dollars and recent product launches under proprietary trademarks, Innovus presents opportunities for collaborations, licensing, or distribution agreements with larger pharmaceutical entities seeking expanding OTC portfolios.

Innovus Pharmaceuticals Tech Stack

Innovus Pharmaceuticals uses 8 technology products and services including RSS, Open Graph, instant.page, and more. Explore Innovus Pharmaceuticals's tech stack below.

  • RSS
    Content Management System
  • Open Graph
    Content Management System
  • instant.page
    Javascript Libraries
  • LiveChat
    Live Chat
  • Braintree
    Payment Processing
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks
  • Facebook
    Widgets

Media & News

Innovus Pharmaceuticals's Email Address Formats

Innovus Pharmaceuticals uses at least 1 format(s):
Innovus Pharmaceuticals Email FormatsExamplePercentage
FLast@innovuspharma.comJDoe@innovuspharma.com
100%

Frequently Asked Questions

Where is Innovus Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's main headquarters is located at Reno, Nevada 89511 United States. The company has employees across 3 continents, including North AmericaAfricaAsia.

What is Innovus Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Innovus Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Innovus Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals is a publicly traded company; the company's stock symbol is INNV.

What is Innovus Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's official website is innovuspharma.com and has social profiles on LinkedInCrunchbase.

What is Innovus Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Innovus Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of April 2026, Innovus Pharmaceuticals has approximately 5 employees across 3 continents, including North AmericaAfricaAsia. Key team members include Managing Partner: M. V. E.Attorney: J. S.. Explore Innovus Pharmaceuticals's employee directory with LeadIQ.

What industry does Innovus Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Innovus Pharmaceuticals use?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's tech stack includes RSSOpen Graphinstant.pageLiveChatBraintreePHPBootstrapFacebook.

What is Innovus Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's email format typically follows the pattern of FLast@innovuspharma.com. Find more Innovus Pharmaceuticals email formats with LeadIQ.

How much funding has Innovus Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of April 2026, Innovus Pharmaceuticals has raised $1.1M in funding. The last funding round occurred on Feb 25, 2014 for $1.1M.

When was Innovus Pharmaceuticals founded?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals was founded in 2011.

Innovus Pharmaceuticals

Pharmaceutical ManufacturingNevada, United States2-10 Employees

Our mission is to in-license, acquire or develop over-the-counter and consumer health care products designed for in-home treatment of medical conditions and ailments to help customers take care of themselves and their families in order to lead healthy lives.

We are a leader in Over-the-Counter, clinically proven Consumer Care Products for Men and Women's Health. Our products are designed to aid with Vitality, Sexual Health, Muscle and Joint Pain, Reproductive Health, Respiratory Issues and General Supportive Care.

For more information on Innovus Pharmaceuticals, please visit: www.innovuspharma.com

Section iconCompany Overview

Headquarters
Reno, Nevada 89511 United States
Phone number
Stock Symbol
INNV
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $1.1M

    Innovus Pharmaceuticals has raised a total of $1.1M of funding over 3 rounds. Their latest funding round was raised on Feb 25, 2014 in the amount of $1.1M.

Section iconFunding & Financials

  • $1.1M

    Innovus Pharmaceuticals has raised a total of $1.1M of funding over 3 rounds. Their latest funding round was raised on Feb 25, 2014 in the amount of $1.1M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.